In short
The Fibrolamellar Cancer Foundation lets grant applicants use AI tools when developing proposals. The application must disclose all AI use and describe how the tools were used. Applicants are fully responsible for the accuracy of their proposals. Members of FCF review committees may not use AI tools to analyze, summarize, or interpret applications, or to write critiques.
Requires disclosure. Applicants may use AI and must say where they used it.
For applicants
- Applicants may use AI tools to develop proposals. They are fully responsible for the accuracy of the content. The application must disclose all AI use and how it was used. [1]
For reviewers
- No member of an FCF review committee may use AI tools to analyze, summarize, or interpret information in a grant application, or to write peer review critiques. This covers both Scientific Reviewers and Community Reviewers. [1]
Sources
AI Use Policy (opens in a new tab)
Grant applicants are permitted to use AI Tools in the development of their proposals. However, applicants are fully responsible for the accuracy of the content of their proposals. All use of AI, and details about how it was used, must be disclosed in the application.
Therefore, members of any FCF review committee, including Scientific Reviewers and Community Reviewers, are not permitted to use AI Tools for analyzing, summarizing, or interpreting information provided in any grant application, or for formulating peer review critiques for grant applications.
See Fibrolamellar Cancer Foundation's 1 open program
This page summarizes what the funder has published and is not legal advice. Policies change, and one solicitation can add its own rules. Confirm against the funding announcement before you apply.